Evidence map›Paper›PMID 26735693›Full record

ArticlePLoS pathogens2016

Lyn Delivers Bacteria to Lysosomes for Eradication through TLR2-Initiated Autophagy Related Phagocytosis.

Xuefeng Li, Sisi He, Xikun Zhou, Yan Ye, Shirui Tan, Shuang Zhang, Rongpeng Li, Min Yu, Michael C Jundt, Alec Hidebrand and 4 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Autophagy, cell death, and cytokines inEmerging microbes & infections · 2023
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Virulence · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xuefeng LiState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, P.R. China.
Sisi HeState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, P.R. China.
Xikun ZhouState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, P.R. China.
Yan YeDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, United States of America.
Shirui TanDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, United States of America.
Shuang ZhangState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, P.R. China.
Rongpeng LiDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, United States of America.
Min YuDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, United States of America.
Michael C JundtDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, United States of America.
Alec HidebrandDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, United States of America.
Yongsheng WangState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, P.R. China.
Guoping LiInflammations & Allergic Diseases Research Unit, Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan, P.R. China.
Canhua HuangState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, P.R. China.
Min WuDepartment of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, United States of America.

Funding

Lung innate immunity against bacterial infectionR01AI109317 · NIAID · UNIVERSITY OF NORTH DAKOTA · PI WU, MIN · 2014 to 2018
$1.7M
Lung epithelium collaborates with alveolar macrophages in host defenseR15AI101973 · NIAID · UNIVERSITY OF NORTH DAKOTA · PI WU, MIN · 2012 to 2012
$414k
Ceramide membrane microdomains regulate cytokine secretionR03AI097532 · NIAID · UNIVERSITY OF NORTH DAKOTA · PI SINGH, BRIJ B · 2012 to 2013
$138k
NIAID NIH HHS AI097532-01A1NIAID NIH HHS AI101973-01NIAID NIH HHS AI109317-01A1NIAID NIH HHS R01 AI109317NIAID NIH HHS R03 AI097532NIAID NIH HHS R15 AI101973
6 · The paper itself

Abstract

Extracellular bacteria, such as Pseudomonas aeruginosa and Klebsiella pneumoniae, have been reported to induce autophagy; however, the role and machinery of infection-induced autophagy remain elusive. We show that the pleiotropic Src kinase Lyn mediates phagocytosis and autophagosome maturation in alveolar macrophages (AM), which facilitates eventual bacterial eradication. We report that Lyn is required for bacterial infection-induced recruitment of autophagic components to pathogen-containing phagosomes. When we blocked autophagy with 3-methyladenine (3-MA) or by depleting Lyn, we observed less phagocytosis and subsequent bacterial clearance by AM. Both morphological and biological evidence demonstrated that Lyn delivered bacteria to lysosomes through xenophagy. TLR2 initiated the phagocytic process and activated Lyn following infection. Cytoskeletal trafficking proteins, such as Rab5 and Rab7, critically facilitated early phagosome formation, autophagosome maturation, and eventual autophagy-mediated bacterial degradation. These findings reveal that Lyn, TLR2 and Rab modulate autophagy related phagocytosis and augment bactericidal activity, which may offer insight into novel therapeutic strategies to control lung infection.

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsAutophagyCell LineDisease Models, AnimalFluorescent Antibody Technique, IndirectHost-Parasite InteractionsImmunoblottingLysosomesMacrophages, AlveolarMiceMicroscopy, ConfocalMicroscopy, Electron, TransmissionPseudomonas aeruginosaPseudomonas InfectionsReal-Time Polymerase Chain ReactionAdaptor Proteins, Vesicular TransportLAB protein, mouselyn protein-tyrosine kinasesrc-Family KinasesTlr2 protein, mouseToll-Like Receptor 2

Identifiers

PMID26735693
PMCPMC4703367

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.